212 related articles for article (PubMed ID: 23556549)
1. Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP).
Thanacoody HK; Gray A; Dear JW; Coyle J; Sandilands EA; Webb DJ; Lewis S; Eddleston M; Thomas SH; Bateman DN
BMC Pharmacol Toxicol; 2013 Apr; 14():20. PubMed ID: 23556549
[TBL] [Abstract][Full Text] [Related]
2. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.
Bateman DN; Dear JW; Thanacoody HK; Thomas SH; Eddleston M; Sandilands EA; Coyle J; Cooper JG; Rodriguez A; Butcher I; Lewis SC; Vliegenthart AD; Veiraiah A; Webb DJ; Gray A
Lancet; 2014 Feb; 383(9918):697-704. PubMed ID: 24290406
[TBL] [Abstract][Full Text] [Related]
3. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.
; Dear J
Trials; 2019 Jan; 20(1):27. PubMed ID: 30621764
[TBL] [Abstract][Full Text] [Related]
4. Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver.
Bateman DN; Dart RC; Dear JW; Prescott LF; Rumack BH
Clin Toxicol (Phila); 2023 Dec; 61(12):1020-1031. PubMed ID: 38197864
[TBL] [Abstract][Full Text] [Related]
5. Changing the Management of Paracetamol Poisoning.
Bateman DN
Clin Ther; 2015 Sep; 37(9):2135-41. PubMed ID: 26233473
[TBL] [Abstract][Full Text] [Related]
6. Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine.
Daoud A; Dalhoff KP; Christensen MB; Bøgevig S; Petersen TS
Clin Toxicol (Phila); 2020 Jul; 58(7):698-704. PubMed ID: 31601129
[No Abstract] [Full Text] [Related]
7. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose.
Pettie JM; Caparrotta TM; Hunter RW; Morrison EE; Wood DM; Dargan PI; Thanacoody RH; Thomas SHL; Elamin MEMO; Francis B; Webb DJ; Sandilands EA; Eddleston M; Dear JW
EClinicalMedicine; 2019; 11():11-17. PubMed ID: 31317129
[TBL] [Abstract][Full Text] [Related]
9. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.
Sun R; Klein KW; White PF
Anesth Analg; 1997 Feb; 84(2):331-6. PubMed ID: 9024023
[TBL] [Abstract][Full Text] [Related]
10. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
Bergese S; Viloria A; Uribe A; Antor A; Fernandez S
Trials; 2012 Aug; 13():130. PubMed ID: 22862827
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication.
Tobias JD; Gregory DF; Deshpande JK
Pediatr Emerg Care; 1992 Dec; 8(6):345-6. PubMed ID: 1360651
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning.
Wong A; Landersdorfer C; Graudins A
Eur J Clin Pharmacol; 2017 Sep; 73(9):1103-1110. PubMed ID: 28624886
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
[TBL] [Abstract][Full Text] [Related]
14. A pragmatic randomized controlled trial of multi-dose oral ondansetron for pediatric gastroenteritis (the DOSE-AGE study): statistical analysis plan.
Heath A; Rios JD; Williamson-Urquhart S; Pechlivanoglou P; Offringa M; McCabe C; Hopkin G; Plint AC; Dixon A; Beer D; Gouin S; Joubert G; Klassen TP; Freedman SB;
Trials; 2020 Aug; 21(1):735. PubMed ID: 32838813
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
16. A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose.
Shen F; Coulter CV; Isbister GK; Duffull SB
Clin Toxicol (Phila); 2011 Aug; 49(7):643-7. PubMed ID: 21854081
[TBL] [Abstract][Full Text] [Related]
17. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine.
Cairney DG; Beckwith HK; Al-Hourani K; Eddleston M; Bateman DN; Dear JW
Clin Toxicol (Phila); 2016 Jun; 54(5):405-10. PubMed ID: 27108714
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
Grunberg SM; Rolski J; Strausz J; Aziz Z; Lane S; Russo MW; Wissel P; Guckert M; Wright O; Herrstedt J
Lancet Oncol; 2009 Jun; 10(6):549-58. PubMed ID: 19428297
[TBL] [Abstract][Full Text] [Related]
19. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.
Pan PH; Lee SC; Harris LC
Anesth Analg; 2008 Aug; 107(2):429-38. PubMed ID: 18633020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
